Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TAP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMolson Coors EMEA&APAC President takes medical leave; UK chief named interim leader
Filed June 24, 2026 · Period ending June 24, 2026 · ~1 min read
Key Changes
-
medium
Philip Whitehead, President and CEO of the EMEA&APAC business unit, is temporarily stepping away due to a medical condition. The filing does not disclose the nature of the condition or expected duration.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Simon Kerry, Managing Director of the UK and Ireland regional business, will serve as interim Managing Director of EMEA&APAC during Whitehead's leave, representing an internal promotion from regional to business-unit leadership.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
Summary
Molson Coors disclosed that Philip Whitehead, who leads its Europe, Middle East, Africa and Asia-Pacific business unit, is taking a temporary medical leave. The company has appointed Simon Kerry, currently head of its UK and Ireland operations, as interim leader of the broader EMEA&APAC region during Whitehead's absence.
The filing provides no details on the medical condition or expected timeline for Whitehead's return. For investors, this is a routine executive continuity disclosure with limited immediate impact. The company has filled the role internally with a regional leader already familiar with the business, suggesting operational continuity. The lack of detail on duration or condition is typical for medical leave announcements. EMEA&APAC represents one of Molson Coors' geographic segments, so leadership stability matters, but the interim arrangement appears orderly.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Philip Whitehead, the President and Chief Executive Officer of the Company’s EMEA&APAC business, will be temporarily stepping away from his role due to a medical condition.
Philip Whitehead, who leads Molson Coors' Europe, Middle East, Africa and Asia-Pacific business unit, is taking a temporary medical leave. The filing does not disclose the nature of the medical condition or expected duration of the leave.
Added in current filing · verify on EDGAR →
Simon Kerry, the Managing Director of the Company’s U.K. and Ireland regional business, will serve as interim Managing Director of the Company’s EMEA&APAC business during Mr. Whitehead’s medical leave period.
Simon Kerry, currently leading the U.K. and Ireland operations, will assume interim leadership of the broader EMEA&APAC region during Whitehead's absence. This represents an internal promotion from a regional role to oversee the entire geographic business unit on a temporary basis.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 24, 2026 · How we verify